Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial
View/
Metadata
Show full item record
Except where otherwise noted, this item's license is described
as
https://creativecommons.org/licenses/by/4.0